BAFNA PHARMACEUTICALS LTD. - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
13 Jan 2022
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 13, 2022 for Mahveer Chand Bafna, Mahaveer Chand Bafna HUF, Sasikala Bafna, Amribai Bafna and Paras Bafna
Source:
BSE India